Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment

por Aggarwal, Rahul, Ryan, Charles J.
Publicado 2011

Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy

por Ryan, Charles J., Morgans, Alicia K.
Publicado 2020

Novel Immune Engagers and Cellular Therapies for Metastatic Castration-Resistant Prostate Cancer: Do we take a BiTe or ride BiKEs, TriKEs, and CARs?

por Zorko, Nicholas A., Ryan, Charles J.
Publicado 2021

Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer—Where Are We Now?

por Rao, Arpit, Moka, Nagaishwarya, Hamstra, Daniel A., Ryan, Charles J.
Publicado 2022

Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review

por Idossa, Dame, Friedlander, Terence, Paller, Channing J., Ryan, Charles J., Borno, Hala T.
Publicado 2022

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors

por Wefel, Jeffrey S., Ryan, Charles J., Van, Julie, Jackson, James C., Morgans, Alicia K.
Publicado 2022

Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility

por Crawford, E. David, Shore, Neal D., Petrylak, Daniel P., Higano, Celestia S., Ryan, Charles J.
Publicado 2017

Genetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer’s Disease

por Carr, Jessie S., Bonham, Luke W., Morgans, Alicia K., Ryan, Charles J., Yokoyama, Jennifer S., Geier, Ethan G.
Publicado 2018

A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer

por Wei, Xiao X., Hsieh, Andrew C., Kim, Won, Friedlander, Terence, Lin, Amy M., Louttit, Mirela, Ryan, Charles J.
Publicado 2017

Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study

por Prizment, Anna E., McSweeney, Sean, Pankratz, Nathan, Joshu, Corinne E., Hwang, Justin H., Platz, Elizabeth A., Ryan, Charles J.
Publicado 2021

Androgen Decline and Survival During Docetaxel Therapy in metastatic Castration Resistant Prostate Cancer (mCRPC)

por Ryan, Charles J, Dutta, Sandipan, Kelly, William K, Russell, Carly, Small, Eric J., Morris, Michael J., Taplin, Mary-Ellen, Halabi, Susan
Publicado 2019

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer

por Magbanua, Mark Jesus M, Sosa, Eduardo V, Scott, Janet H, Simko, Jeff, Collins, Colin, Pinkel, Dan, Ryan, Charles J, Park, John W
Publicado 2012

How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials

por Borno, Hala T., Small, Eric J., Zhang, Li, DeRouen, Mindy C., Griffin, Ann, McGuire, Joseph, Ryan, Charles J., Hiatt, Robert A., Kaplan, Celia P.
Publicado 2019

Exercise in advanced prostate cancer elevates myokine levels and suppresses in-vitro cell growth

por Kim, Jin-Soo, Taaffe, Dennis R., Galvão, Daniel A., Hart, Nicolas H., Gray, Elin, Ryan, Charles J., Kenfield, Stacey A., Saad, Fred, Newton, Robert U.
Publicado 2022

A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cance...

por Wei, Xiao X., Siegel, Adam P., Aggarwal, Rahul, Lin, Amy M., Friedlander, Terence W., Fong, Lawrence, Kim, Won, Louttit, Mirela, Chang, Emily, Zhang, Li, Ryan, Charles J.
Publicado 2018

Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States

por Ryan, Charles J., Ke, Xuehua, Lafeuille, Marie-Hélène, Romdhani, Hela, Kinkead, Frederic, Lefebvre, Patrick, Petrilla, Allison, Pulungan, Zul, Kim, Seung, D'Andrea, Denise M., Francis, Peter, Freedland, Stephen J.
Publicado 2021

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

por Vallera, Daniel A., Ferrone, Soldano, Kodal, Behiye, Hinderlie, Peter, Bendzick, Laura, Ettestad, Brianna, Hallstrom, Caroline, Zorko, Nicholas A., Rao, Arpit, Fujioka, Naomi, Ryan, Charles J., Geller, Melissa A., Miller, Jeffrey S., Felices, Martin
Publicado 2020

Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer

por Shi, Xiaolei, Day, Abderrahman, Bergom, Hannah E., Tape, Sydney, Baca, Sylvan C., Sychev, Zoi E., Larson, Gabrianne, Bozicevich, Asha, Drake, Justin M., Zorko, Nicholas, Wang, Jinhua, Ryan, Charles J., Antonarakis, Emmanuel S., Hwang, Justin
Publicado 2022

Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Can...

por Smith, Matthew R., Antonarakis, Emmanuel S., Ryan, Charles J., Berry, William R., Shore, Neal D., Liu, Glenn, Alumkal, Joshi J., Higano, Celestia S., Maneval, Edna Chow, Bandekar, Rajesh, de Boer, Carla J., Yu, Margaret K., Rathkopf, Dana E.
Publicado 2016

Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial

por Morris, Michael J., Loriot, Yohann, Sweeney, Christopher J., Fizazi, Karim, Ryan, Charles J., Shevrin, Daniel H., Antonarakis, Emmanuel S., Pandit-Taskar, Neeta, Deandreis, Désirée, Jacene, Heather A., Vesselle, Hubert, Petrenciuc, Oana, Lu, Cindy, Carrasquillo, Jorge A., Higano, Celestia S.
Publicado 2019